AstraZeneca Strengthens its Cardiovascular Pipeline with Agreement for a Pre-Clinical Novel Lipid-Lowering Therapy
October 8, 2024
0
AstraZeneca Agreement with CSPC Pharmaceutical Group Yesterday, October 7, 2024, AstraZeneca (AZN) announced it entered into an exclusive license agreement with CSPC Pharmaceutical Group Ltd (CSPC) to advance . . . This content is for paid subscribers. Please click here to subscribe or here to log in.